Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Ishibashi, Kei; Haber, Tobias; Breuksch, Ines et al.
Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockadeONCOTARGET. Bd. 8. H. 33. 2017 S. 55230-55245
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionColloquium Senologie 2017/2018. München: Agileum Verlagsgesellschaft mbH 2017
Trautmann, F.; Singer, S.; Schmitt, J.
Patients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer-free individuals. A secondary data analysisEUROPEAN JOURNAL OF CANCER CARE. Bd. 26. H. 6. 2017
Bartmann, Catharina; Wischnewsky, Manfred; Stueber, Tanja et al.
Pattern of metastatic spread and subcategories of breast cancerARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 295. H. 1. 2017 S. 211-223
Holzhaeuser, E.; Berlin, M.; Wollschlaeger, D. et al.
Patterns of failure of Diffuse Large B-Cell Lymphoma (DLBCL) patients after Involved Site Radiotherapy (ISRT)STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 193. 2017 S. S5-S5
Holzhaeuser, Eva; Berlin, Maximilian; Wollschlger, Daniel et al.
Patterns of failure of diffuse large BaEurocell lymphoma patients after involved-site radiotherapySTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 193. H. 12. 2017 S. 1014-1023
Dinkic, C.; Eichbaum, M.; Schmidt, M. et al.
Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant,recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trialGYNECOLOGIC ONCOLOGY. Bd. 146. H. 2. 2017 S. 279-284
Kalasauskas, D; Renovanz, M; Bikar, S et al.
Perspectives and Challenges in Molecular-Based Diagnostics and PersonalizedCarcinogenesis and Mutagenesis. 2017 S. 1000290
Borchmann, Peter; Goergen, Helen; Kobe, Carsten et al.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study GroupLANCET. Bd. 390. H. 10114. 2017 S. 2790-2802
Rades, Dirk; Maderer, Annett; Panzner, Annika et al.
Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal CancerANTICANCER RESEARCH. Bd. 37. H. 5. 2017 S. 2703-2708